If you are having problems accessing, please clear your browser data (cache and cookies) for the last 4 weeks and try again. If you are still having problems, please contact us at +47 21 555 888.
Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Absa Group Limited | AU61 | Apr 25, 2025 | 7.70 | -1.91 |
ABSOLICON SOLAR COLLEC. B | ZY0 | Apr 25, 2025 | 0.24 | -4.69 |
AC Immune SA | IMR | Apr 25, 2025 | 1.40 | +11.31 |
Acacia Research Corporation | AZG2 | Apr 25, 2025 | 2.80 | +10.24 |
AcadeMedia | V8T | Apr 25, 2025 | 7.29 | +2.39 |
Acadia Healthcare Company, Inc. | 7RA | Apr 25, 2025 | 19.50 | -7.14 |
ACADIA Pharmaceuticals Inc. | DR6 | Apr 25, 2025 | 13.03 | +1.68 |
Acadia Realty Trust | WX1 | Apr 25, 2025 | 17.20 | -1.71 |
Acadian Timber Corp | 779 | Apr 25, 2025 | 10.60 | +0.95 |
Acanthe Developpement SA | ADX | Apr 25, 2025 | 0.29 | +1.75 |
Acarix | 7AC | Apr 25, 2025 | 0.02 | -11.94 |
Acast AB | 0PN | Apr 25, 2025 | 1.20 | +3.98 |
Accelerate Diagnostics | 1A80 | Apr 25, 2025 | 0.48 | -0.42 |
ACCELLERON IND. ADR/1 | ZH20 | Apr 25, 2025 | 43.40 | +5.85 |
Accent Resources NL | A2R | Apr 25, 2025 | 0.01 | 0.00 |
Accentis S.A. | D1Z | Apr 25, 2025 | 0.03 | -1.89 |
Accentro Real Estate AG | A4Y | Apr 25, 2025 | 0.28 | +300.00 |
Accenture plc Class A Ordinary Shares (Ireland) | CSA | Apr 25, 2025 | 255.90 | +2.44 |
Accesso Technology Group Plc | LQG | Apr 25, 2025 | 4.96 | +3.33 |
Acciona SA | AJ3 | Apr 25, 2025 | 121.90 | +8.26 |
Acco Brands Corporation | A3B | Apr 25, 2025 | 3.34 | +5.70 |
Acconeer | 2LU | Apr 25, 2025 | 0.46 | +0.88 |
Accor | ACR1 | Apr 25, 2025 | 8.50 | +11.11 |
Accor SA | ACR | Apr 25, 2025 | 40.97 | +5.32 |
Accsys Technologies | 1D8 | Apr 25, 2025 | 0.51 | +0.20 |
Accuray Incorporated | XEJ | Apr 25, 2025 | 1.34 | +5.51 |
Ace Hardware Indonesia TBK | 4AH1 | Apr 25, 2025 | 0.02 | -7.50 |
ACE LIBERTY+STONE LS -,25 | 8MW | Apr 25, 2025 | 0.49 | +0.41 |
ACEA SpA | DCA | Apr 25, 2025 | 19.52 | +1.77 |
AcelRx Pharmaceuticals | R5XA | Apr 25, 2025 | 0.42 | +14.27 |
|
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.